Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Heider

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
International Journal for Parasitology|March 21, 2006
RNAi mediated silencing of actin expression in adult Litomosoides sigmodontis is specific, persistent and results in a phenotypeKenneth Pfarr, Ulrike Heider, Achim Hoerauf
Leukemia Research|May 15, 2002
Angiogenesis in multiple myelomaOrhan Sezer, Kathrin Niemöller, Christian Jakob, et al.
International Journal of Medical Microbiology : IJMM|April 18, 2006
Differential display of genes expressed in the filarial nematode Litomosoides sigmodontis reveals a putative phosphate permease up-regulated after depletion of Wolbachia endobacteriaUlrike Heider, Mark Blaxter, Achim Hoerauf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Human bone marrow myeloma cells express RANKLOrhan Sezer, Ulrike Heider, Christian Jakob, et al.
Cancer Research|January 28, 2004
Identification and clinical relevance of receptor activator of nuclear factor kappaB ligand expression of myeloma cellsUlrike Heider, Ivana Zavrski, Christian Jakob, et al.
British Journal of Haematology|April 30, 2003
Circulating hepatocyte growth factor levels in multiple myelomaChristian Jakob, Claudia Fleissner, Ivana Zavrski, et al.
European Journal of Haematology|August 22, 2003
Bisphosphonates in early multiple myelomaOrhan Sezer, Christian Jakob, Ivana Zavrski, et al.
Journal of Immunotherapy and Precision Oncology|March 11, 2025
Incidence and Factors Associated with Graft-Versus-Host Disease in the First Year After Allogeneic Peripheral Blood Stem Cell TransplantationUlrike Heider, Julio Solano-Vega, Y Gisella Sandoval-Vargas, et al.
Annals of Hematology|May 6, 2009
Therapeutic implication of BAL in patients with neutropeniaDagmar Kuehnhardt, Manja Hannemann, Bernd Schmidt, et al.
Blood|November 9, 2002
RANK ligand and osteoprotegerin in myeloma bone diseaseOrhan Sezer, Ulrike Heider, Ivana Zavrski, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
International Journal for Parasitology|March 21, 2006
RNAi mediated silencing of actin expression in adult Litomosoides sigmodontis is specific, persistent and results in a phenotypeKenneth Pfarr, Ulrike Heider, Achim Hoerauf
Leukemia Research|May 15, 2002
Angiogenesis in multiple myelomaOrhan Sezer, Kathrin Niemöller, Christian Jakob, et al.
International Journal of Medical Microbiology : IJMM|April 18, 2006
Differential display of genes expressed in the filarial nematode Litomosoides sigmodontis reveals a putative phosphate permease up-regulated after depletion of Wolbachia endobacteriaUlrike Heider, Mark Blaxter, Achim Hoerauf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Human bone marrow myeloma cells express RANKLOrhan Sezer, Ulrike Heider, Christian Jakob, et al.
Cancer Research|January 28, 2004
Identification and clinical relevance of receptor activator of nuclear factor kappaB ligand expression of myeloma cellsUlrike Heider, Ivana Zavrski, Christian Jakob, et al.
British Journal of Haematology|April 30, 2003
Circulating hepatocyte growth factor levels in multiple myelomaChristian Jakob, Claudia Fleissner, Ivana Zavrski, et al.
European Journal of Haematology|August 22, 2003
Bisphosphonates in early multiple myelomaOrhan Sezer, Christian Jakob, Ivana Zavrski, et al.
Journal of Immunotherapy and Precision Oncology|March 11, 2025
Incidence and Factors Associated with Graft-Versus-Host Disease in the First Year After Allogeneic Peripheral Blood Stem Cell TransplantationUlrike Heider, Julio Solano-Vega, Y Gisella Sandoval-Vargas, et al.
Annals of Hematology|May 6, 2009
Therapeutic implication of BAL in patients with neutropeniaDagmar Kuehnhardt, Manja Hannemann, Bernd Schmidt, et al.
Blood|November 9, 2002
RANK ligand and osteoprotegerin in myeloma bone diseaseOrhan Sezer, Ulrike Heider, Ivana Zavrski, et al.
Pageof 5